PharmaBlock Sciences (Nanjing), Inc. (300725.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2455
First IPO Date
November 10, 2017
| Name | Title | Pay | Year Born |
| Minmin Yang | Co-Founder, Chairman & Chief Executive Officer | 0 | 1972 |
| David Chen | Executive Vice President, Chief Operation Officer & Head of CDMO | 0 | N/A |
| Dezhi Sha | Sr. VP of Process Technology & Manufacturing | 0 | N/A |
| Jing Li | Sr. VP of Process Chemistry & President of PharmaBlock (USA), Inc. | 0 | 1973 |
| Shijie Zhang | Chief Technology Officer | 0 | 1964 |
| Shuhai Zhao | Co-founder & Chief Scientific Officer | 0 | 1963 |
| Shanbao Yu | Secretary of the Board | 0 | 1982 |
| Zhiho Ng Chen | Executive Vice President | 0 | 1957 |
PharmaBlock Sciences (Nanjing), Inc. delivers a comprehensive suite of chemical products and specialized services, supporting the pharmaceutical industry across the full spectrum of its operations – from initial research and development phases to large-scale commercial production. The company's primary offerings encompass: A vast inventory of chemical building blocks, available for supply at every stage of drug creation, from early discovery through to advanced development and commercial manufacturing. The creation of diverse chemical libraries, derived from their building blocks, specifically designed to accelerate drug discovery processes. Contract development and manufacturing (CDMO) services for essential pharmaceutical components, including raw starting materials (RSMs), chemical intermediates, active pharmaceutical ingredients (APIs), and finished drug products, catering to both clinical development programs and market demands. Established in 2006, PharmaBlock Sciences maintains its corporate headquarters in Nanjing, People's Republic of China.